Was this insider webinar meant to target investors or what
How can anyone rate this as good i will never know
Diamond kicks in by saying we are looking at advancing our pipeline of drugs we have two compounds we call them ATl1101 and Atl1102 multiple successful Ph2 trials ( REALLY what a F#N Joke this guy is )
ATL1101 my ass
Todays presentation he is going to focus on ATL1102 ( WHY 1102 is this an investment seminar or not )
His presentation itself on DMD was not that bad, but in all fairness is should be outstanding the number of times he has presented this, it should be flawless
so lets move past the dmd preso and onto
near and medium term value drivers
40min mark for me the whole thing falls apart, his mouse movements are as erratic as his speech
Talks on near term drivers yet refuses to talk on ATL1103,is it a near term driver or not ( don't you think this would be of major interest to the potential investors listening to this, if near term we are going to partner ATL1103 What a joke this guy is )
40.45sec summary ad value drivers
( once again totally ignores ATL1103 and its partnering unbelievable)
42min questions
question asked on companion therapy and partnering
well this investor must have had no clue at the end of Diamonds answer
Talk about rambling on
I presume because there was a mention of joint therapy the question was directed at would we possibly be looking at partnering/collaborating with any of the dystrophy pharma's in the DMD field
Diamond went of on a stuttering rant to goodness knows where it was embarrassing to say the least and as an investor please DO NOT MEINTION the word PARTNERING it would appear its a taboo word and only talked about in the inner circles.
I understand time was a restraint but if you are looking to investors to invest, you don't side step what could turn out to be a major milestone in the possible partnering near term of Atl1103
some time should have been spent on its promotion
Sorry another fail for mine
On a side note nothing in the the request for loyalty options in the AGM as in no resolution put forward
This path is reminiscent of the Pattos days CR tap the big boys when required and let the long term suffering shareholders do exactly that suffer
The thing that got me, Diamond was basically boasting that he had gotten rid of the overhang from AEF in a X trade
our number 1 holder
These people at one stage had over 70mil shares in ANP and this guy is glad to see the back of them
OR WAS IT THE OTHER WAY AROUND
WHAT these people put us where we sit today and he is glad they are gone
No one has actually bothered to ask this
but this fund in AEF did their DD when they got onboard, has anyone here thought to ask
WHY
WHY have they left the building if we have so much potential
Is it because they could see our CEO could not PROMOTE a free P!$$ up in a brewery
Good question i think and one all shareholders should be mindful of
Not sure if i will support the SPP as yet for the dregs we are being offered short term opps elsewhere for my liking
I have a respectable holding just outside the top 20 took some off when i converted my oppis and invested elsewhere have already tripled that investment so was the correct decision
I do intend to stick around, just sick of supporting this guys wages that's all
I will be voting against the remuneration this year once more, just to voice my dissatisfaction on the arrogance of these people
- Forums
- ASX - By Stock
- Ann: Investor Presentation
Was this insider webinar meant to target investors or what How...
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.6¢ |
Change
-0.003(3.37%) |
Mkt cap ! $77.53M |
Open | High | Low | Value | Volume |
8.9¢ | 8.9¢ | 8.5¢ | $584.3K | 6.750M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 379793 | 8.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.8¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 379793 | 0.086 |
2 | 1002917 | 0.085 |
6 | 250211 | 0.084 |
6 | 610240 | 0.083 |
8 | 415283 | 0.082 |
Price($) | Vol. | No. |
---|---|---|
0.088 | 100000 | 1 |
0.089 | 181074 | 2 |
0.090 | 600000 | 2 |
0.095 | 55000 | 1 |
0.096 | 55977 | 1 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online